Medicare Enrolled

Dr. Alexei Arkhipov, M.D.

Hematology & Oncology · San Antonio, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
88 BRIGGS ST STE 280, San Antonio, TX 78224
2109221977
Registered in NPPES since 2006
NPI: 1700980299 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Arkhipov from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Arkhipov? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Arkhipov

Dr. Alexei Arkhipov is a hematology & oncology specialist in San Antonio, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Arkhipov performed 1,816 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Arkhipov received a total of $15,378 from 55 pharmaceutical and/or device companies across 651 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Arkhipov is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 44% volume in TX $15,378 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,816
Medicare services
Top 44% in TX for hematology & oncology
Not available
Unique patients (not deduplicated)
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
1,456 $61 $108
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
139 $132 $300
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
87 $135 $194
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
53 $8 $34
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
39 $90 $137
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
28 $69 $97
New patient office visit, complex (60-74 min) 14 $156 $216
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$15,378
Total received (2018-2024)
Avg $2,197/year across 7 years
Top 25% in TX for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
651
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,990
2023
$2,832
2022
$2,575
2021
$2,622
2020
$2,007
2019
$1,873
2018
$1,478

Payments by company (2024)

Janssen Biotech, Inc.
$336
Novartis Pharmaceuticals Corporation
$222
PFIZER INC.
$159
GENZYME CORPORATION
$158
Incyte Corporation
$150
AstraZeneca Pharmaceuticals LP
$135
GlaxoSmithKline, LLC.
$114
Janssen Pharmaceuticals, Inc
$111
Merck Sharp & Dohme LLC
$107
Daiichi Sankyo Inc.
$102
Eisai Inc.
$84
Celgene Corporation
$60
Takeda Pharmaceuticals U.S.A., Inc.
$58
Aveo Pharmaceuticals, Inc.
$52
E.R. Squibb & Sons, L.L.C.
$38
ADC Therapeutics America, Inc.
$35
SOBI, INC
$27
SHIELD THERAPEUTICS INC
$22
ARRAY BIOPHARMA INC
$20
Top 3 companies account for 36.0% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$2,008
Novartis Pharmaceuticals Corporation
$1,740
PFIZER INC.
$1,732
Janssen Pharmaceuticals, Inc
$1,465
E.R. Squibb & Sons, L.L.C.
$1,241
AstraZeneca Pharmaceuticals LP
$804
Daiichi Sankyo Inc.
$513
GlaxoSmithKline, LLC.
$414
Dova Pharmaceuticals
$384
Merck Sharp & Dohme Corporation
$382
Boehringer Ingelheim Pharmaceuticals, Inc.
$349
Merck Sharp & Dohme LLC
$336
ARRAY BIOPHARMA INC
$319
Celgene Corporation
$312
GENZYME CORPORATION
$232
Incyte Corporation
$208
Astellas Pharma US Inc
$177
Rigel Pharmaceuticals, Inc.
$167
SOBI, INC
$159
Teva Pharmaceuticals USA, Inc.
$155
COMSORT, Inc
$150
Bayer HealthCare Pharmaceuticals Inc.
$145
Takeda Pharmaceuticals U.S.A., Inc.
$132
TerSera Therapeutics LLC
$128
Pharmacyclics LLC, An AbbVie Company
$127
Janssen Scientific Affairs, LLC
$118
Gilead Sciences, Inc.
$116
Eisai Inc.
$105
Jazz Pharmaceuticals Inc.
$94
ADC Therapeutics America, Inc.
$94
Shield Therapeutics Inc
$94
CSL Behring
$90
Lilly USA, LLC
$78
AMAG Pharmaceuticals, Inc.
$73
Helsinn Therapeutics (U.S.), Inc.
$64
Sobi, Inc
$61
Bayer Healthcare Pharmaceuticals Inc.
$57
Aveo Pharmaceuticals, Inc.
$52
AVEO Pharmaceuticals, Inc.
$50
EISAI INC.
$49
Foundation Medicine, Inc.
$49
Exelixis Inc.
$48
Global Blood Therapeutics, Inc.
$42
Amgen Inc.
$42
Genentech USA, Inc.
$34
Genmab U.S., Inc.
$33
Novo Nordisk Inc
$24
Seagen Inc.
$23
SHIELD THERAPEUTICS INC
$22
CTI BioPharma Corp.
$16
Heron Therapeutics, Inc.
$16
Boston Scientific Corporation
$15
Ipsen Biopharmaceuticals, Inc
$15
PUMA BIOTECHNOLOGY, INC.
$14
Tactile Systems Technology Inc
$13
Top 3 companies account for 35.6% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AKYNZEO · Afstyla · BALVERSA · BAVENCIO · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · CABLIVI · CALQUENCE · CARVYKTI · CYRAMZA · Cabometyx · Cinvanti · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · ERLEADA · Enhertu · Epkinly · Erleada · Esperoct · FERAHEME · FLEXITOUCH · FOTIVDA · FOUNDATIONONE · Fabhalta · GAZYVA · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · INLYTA · INVOKANA · Idelvion · Imbruvica · JADENU · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MYLOTARG · NERLYNX · NINLARO · Nplate · Nubeqa · OJJAARA · OPDIVO · OXBRYTA · PADCEV · PIQRAY · PROMACTA · Pomalyst · REBLOZYL · RYBREVANT · RYDAPT · Rezlidhia · SARCLISA · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · SPRYCEL · Stivarga · TAGRISSO · TALZENNA · TASIGNA · TECVAYLI · TIVDAK · Tavalisse · TheraSphere Y90 Glass Microspheres 10 GBq · Trodelvy · VENCLEXTA · VERZENIO · Vonjo · XALKORI · XARELTO · XTANDI · Xermelo · ZEJULA · ZEPZELCA · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in San Antonio?
Compare hematology & oncology specialists in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
56
County median income
$70,571
Nearest hospital to ZIP centroid (approximate)
CHILDREN'S HOSPITAL OF SAN ANTONIO
7.8 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Arkhipov is a mixed practice specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Arkhipov experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Arkhipov performed 1,456 hospital follow-up visit, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Arkhipov receive payments from pharmaceutical companies?
Yes. Dr. Arkhipov received a total of $15,378 from 55 companies across 651 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Arkhipov's costs compare to other hematology & oncology specialists in San Antonio?
Dr. Arkhipov's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Arkhipov) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →